Related Experiment Video
Updated: May 29, 2026
09:52
Non-invasive Optical Imaging of the Lymphatic Vasculature of a Mouse
Published on: March 8, 2013
Quantum dots trace lymphatic drainage from the mouse eye.
Alex L C Tam1, Neeru Gupta, Zhexue Zhang
1Department of Ophthalmology and Vision Sciences, University of Toronto, M5T 2S8, Canada.
Nanotechnology
|September 22, 2011
Summary
Researchers found evidence of lymphatic drainage from the mouse eye, a novel finding that could lead to new glaucoma treatments. This study visualizes quantum dot tracers to demonstrate fluid removal pathways, offering hope for reducing eye pressure and preventing blindness.
Area of Science:
- Ophthalmology
- Immunology
- Anatomy
Background:
- Glaucoma is a primary cause of blindness globally, characterized by elevated intraocular pressure.
- Current treatments focus on enhancing aqueous humor outflow to reduce eye pressure.
- Recent discoveries identified lymphatic vessels within the human eye.
Purpose of the Study:
- To investigate the presence and pathway of lymphatic drainage from the eye in a mouse model.
- To explore the potential role of ocular lymphatic circulation in fluid homeostasis.
- To establish a novel imaging method for studying ocular lymphatic function.
Main Methods:
- Intraocular injection of quantum dots as fluorescent tracers in 17 live mice.
- Whole-body hyperspectral fluorescence imaging at multiple time points post-injection.
- Confocal microscopy of immunofluorescence-labeled eye sections to confirm tracer localization.
Main Results:
- Quantum dot signal detected in the neck region 6 hours after ocular injection.
- Confirmation of tracer presence within the submandibular lymph node via confocal microscopy.
- First direct evidence of lymphatic drainage from the mouse eye established.
Conclusions:
- The study provides the first direct evidence of lymphatic drainage from the mouse eye.
- Quantum dots serve as an effective tool for in vivo imaging of ocular lymphatic pathways.
- This research may pave the way for novel therapeutic strategies targeting ocular fluid dynamics to treat glaucoma.
